PLIANT THERAPEUTICS INC (PLRX) Stock Analyst Earnings Estimates
NASDAQ:PLRX - Nasdaq - US7291391057 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.57M -81.90% | 9.69M 28.01% | 1.58M -83.69% | -100.00% | 1.762M | 4.533M 157.26% | 28.794M 535.21% | 134.63M 367.56% | 454.63M 237.69% | 977.34M 114.97% | 1.663B 70.16% | 1.886B 13.41% | |
| EBITDA YoY % growth | -96M -137.98% | -125.38M -30.60% | -182.304M -45.40% | -242.781M -33.17% | -272.959M -12.43% | -324.44M -18.86% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -97.54M -134.19% | -127.2M -30.41% | -184.145M -44.77% | -242.943M -31.93% | -255.136M -5.02% | -276.789M -8.49% | -281.688M -1.77% | -204.608M 27.36% | 115.43M 156.42% | 515.72M 346.78% | 1.06B 105.54% | 1.214B 14.53% | |
| Operating Margin | -1,288.51% | -1,312.69% | -11,654.75% | N/A | -14,479.89% | -6,106.09% | -978.29% | -151.98% | 25.39% | 52.77% | 63.74% | 64.37% | |
| EPS YoY % growth | -2.71 -22.68% | -2.97 -9.55% | -2.76 7.07% | -3.71 -34.25% | -3.82 -3.23% | -3.71 2.90% | -3.63 2.15% | -2.07 42.90% | 3.30 258.88% | 8.24 150.08% | 15.80 91.62% | 13.47 -14.71% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.00 -45.27% | -0.92 -18.51% | -0.94 -1.72% | -0.95 -0.39% | -1.10 -10.04% | -1.04 -12.55% | -1.04 -11.17% | -1.04 -9.09% | -1.01 8.45% |
| Revenue Q2Q % growth | 204K | -100.00% | |||||||
| EBITDA Q2Q % growth | -65.28M -44.44% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -64.321M -36.75% | -62.75M -19.77% | -62.274M -2.70% | -62.664M -1.05% | -67.555M -5.03% | -73.653M -17.37% | -73.603M -18.19% | -73.398M -17.13% | -70.991M -5.09% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.95 -35.71% | -0.99 | 0.04 | 3.90% |
| Q2 2024 Q2Q % growth | -0.92 -31.43% | -0.87 | -0.05 | -6.32% |
| Q1 2024 Q2Q % growth | -0.78 -16.42% | -0.79 | 0.01 | 0.89% |
| Q4 2023 Q2Q % growth | -0.69 4.17% | -0.83 | 0.14 | 16.88% |
| Q3 2023 Q2Q % growth | -0.70 -7.69% | -0.79 | 0.09 | 11.45% |
| Q2 2023 Q2Q % growth | -0.70 14.63% | -0.73 | 0.03 | 3.79% |
| Q1 2023 Q2Q % growth | -0.67 14.10% | -0.68 | 0.01 | 1.72% |
| Q4 2022 Q2Q % growth | -0.72 -5.73% | -0.71 | -0.01 | -0.83% |
| Q3 2022 Q2Q % growth | -0.65 13.33% | -0.76 | 0.11 | 14.02% |
| Q2 2022 Q2Q % growth | -0.82 -28.12% | -0.83 | 0.01 | 1.02% |
| Q1 2022 Q2Q % growth | -0.78 -21.88% | -0.77 | -0.02 | -1.96% |
| Q4 2021 Q2Q % growth | -0.68 -26.11% | -0.78 | 0.09 | 12.15% |
| Q3 2021 Q2Q % growth | -0.75 -59.57% | -0.70 | -0.05 | -6.56% |
| Q2 2021 Q2Q % growth | -0.64 53.96% | -0.68 | 0.04 | 6.29% |
| Q1 2021 Q2Q % growth | -0.64 | -0.62 | -0.02 | -3.88% |
| Q4 2020 Q2Q % growth | -0.54 | -0.73 | 0.19 | 25.70% |
| Q3 2020 Q2Q % growth | -0.47 | -0.87 | 0.40 | 45.69% |
| Q2 2020 Q2Q % growth | -1.39 | -0.79 | -0.60 | -76.24% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 541.875K | -541.875K | -100.00% | |
| Q2 2024 Q2Q % growth | -100.00% | 498.097K | -498.097K | -100.00% |
| Q1 2024 Q2Q % growth | -100.00% | 473.79K | -473.79K | -100.00% |
| Q4 2023 Q2Q % growth | -100.00% | 510K | -510K | -100.00% |
| Q3 2023 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q2 2023 Q2Q % growth | 248K -95.03% | 899.456K | -651.456K | -72.43% |
| Q1 2023 Q2Q % growth | 1.332M 6.56% | 1.239M | 93K | 7.51% |
| Q4 2022 Q2Q % growth | 1.97M -1.50% | 1.459M | 511K | 35.02% |
| Q3 2022 Q2Q % growth | 1.48M -8.07% | 1.625M | -145K | -8.92% |
| Q2 2022 Q2Q % growth | 4.99M 178.77% | 1.224M | 3.766M | 307.68% |
| Q1 2022 Q2Q % growth | 1.25M -42.40% | 1.071M | 179K | 16.71% |
| Q4 2021 Q2Q % growth | 2M -55.26% | 2.55M | -550K | -21.57% |
| Q3 2021 Q2Q % growth | 1.61M -66.53% | 2.423M | -813K | -33.55% |
| Q2 2021 Q2Q % growth | 1.79M -50.28% | 3.188M | -1.398M | -43.85% |
| Q1 2021 Q2Q % growth | 2.17M -92.50% | 3.239M | -1.069M | -33.00% |
| Q4 2020 Q2Q % growth | 4.47M | 3.434M | 1.036M | 30.17% |
| Q3 2020 Q2Q % growth | 4.81M | 2.55M | 2.26M | 88.63% |
| Q2 2020 Q2Q % growth | 3.6M | 2.55M | 1.05M | 41.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.57% | -8.27% | 0.16% | 0.13% |
| Revenue | -100% | -100% | N/A | -100% |